Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 4 of 4 items.
Archived – Important Safety Information Concerning Liver Problems for Patients Taking ACCOLATE® (Zafirlukast) – AstraZeneca Canada Inc. – For the Public
AlertHealth professional risk communication | 2004-04-19
Archived – Important Safety Information Regarding the Association Between CRESTOR (Rosuvastatin) and Rhabdomyolysis
AlertHealth professional risk communication | 2004-06-22
Important Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health Professionals
AlertHealth professional risk communication | 2004-04-19
Archived – Updated safety information regarding Crestor
AlertPublic advisory | 2004-11-24